Document is current
Any future updates will be listed below
-
Authors
Hartmann, Maximilian
Servotte, Nathalie https://orcid.org/0000-0002-3330-6482
Aris, Emmanuel https://orcid.org/0000-0001-8640-1742
Doherty, T. Mark https://orcid.org/0000-0003-3009-7969
Salem, Ahmed https://orcid.org/0000-0003-0704-8085
Beck, Ekkehard https://orcid.org/0000-0002-2022-9190
-
Funding
Funding for this research was provided by:
GSK
- License Information
-
More Information
Article History
Received: 21 December 2023
Accepted: 19 September 2024
First Online: 25 October 2024
Declarations
:
: No direct subject contact or primary collection of individual human subject data occurred in this study, which used secondary databases and was conducted under approval of a GSK internal review committee. Since Health Insurance Portability and Accountability Act (HIIPA) compliant and pseudonymized individual data were used, and only aggregated results were presented, no further ethic approval was sought.
: Not applicable.
: NS, EA, MD, AS are employed and hold shares in GSK. EB was employed and hold shares in GSK during the conduct of the study. MH was affiliated with GSK and received accommodation subsidy during the conduct of the study. All authors declare no other financial and non-financial relationships and activities.
